Patients undergoin surgery for breast cancer, according to DSMIV.
Conditions
Interventions
Product Name: Prilokainhydroklorid 5mg/ml
Pharmaceutical Form: Solution for infusion
INN or Proposed INN: Prilocaine hydrochloride
CAS Number: 1786-81-8
Concentration unit: mg/ml milligram(s)/millilit
Sponsors
Karolinska University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All adult patients (99% will be women). Undergoing surgery for breast cancer with a drain inserted into the wound cavity. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Patients with known allergy to Prilokain Patientswho can´t talk or understand the Swedish language. Patient undergoing primary or secondary reconstructive surgery in conjunction with the breast surgical intervention.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary end point(s): Assessment of pain and the effect of adding local anaestetics into the drains when they are removed after breast cancer surgery. ;Main Objective: Is there any significant alleviation of pain when we add local anastetic into the drainage before its removal?;Secondary Objective: Are there any positive or negative consequences when we add fluid into the drainage? | — |
Countries
Sweden
Outcome results
None listed